TrialEuropean journal of anaesthesiology2020

A nebulised antitumour necrosis factor receptor-1 domain antibody in patients at risk of postoperative lung injury: A randomised, placebo-controlled pilot study.

James Ryan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.